AGT and diabetes mellitus: However, in the kidney of patients with diabetes, SGLT2 inhibitors locally decrease renal angiotensinogen (AGT) expression by reducing glucose levels in the early proximal tubes [31], leading to increase in glucose load in the distal proximal tubule, which could increase AGT production [32].